P50 CA 058187/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
2006	3
2007	1
2008	1
2009	1
2013	1
2014	1
2024	0

1

The bronchioloalveolar carcinoma and peripheral adenocarcinoma spectrum of diseases.

Garfield DH, Cadranel JL, Wislez M, Franklin WA, Hirsch FR. Garfield DH, et al. J Thorac Oncol. 2006 May;1(4):344-59. J Thorac Oncol. 2006. PMID: 17409882 Free article. Review.

2

Restoring E-cadherin expression increases sensitivity to epidermal growth factor receptor inhibitors in lung cancer cell lines.

Witta SE, Gemmill RM, Hirsch FR, Coldren CD, Hedman K, Ravdel L, Helfrich B, Dziadziuszko R, Chan DC, Sugita M, Chan Z, Baron A, Franklin W, Drabkin HA, Girard L, Gazdar AF, Minna JD, Bunn PA Jr. Witta SE, et al. Cancer Res. 2006 Jan 15;66(2):944-50. doi: 10.1158/0008-5472.CAN-05-1988. Cancer Res. 2006. PMID: 16424029

3

Analysis of c-ErbB1/epidermal growth factor receptor and c-ErbB2/HER-2 expression in bronchial dysplasia: evaluation of potential targets for chemoprevention of lung cancer.

Merrick DT, Kittelson J, Winterhalder R, Kotantoulas G, Ingeberg S, Keith RL, Kennedy TC, Miller YE, Franklin WA, Hirsch FR. Merrick DT, et al. Clin Cancer Res. 2006 Apr 1;12(7 Pt 1):2281-8. doi: 10.1158/1078-0432.CCR-05-2291. Clin Cancer Res. 2006. PMID: 16609045

4

A constitutional balanced t(3;8)(p14;q24.1) translocation results in disruption of the TRC8 gene and predisposition to clear cell renal cell carcinoma.

Poland KS, Azim M, Folsom M, Goldfarb R, Naeem R, Korch C, Drabkin HA, Gemmill RM, Plon SE. Poland KS, et al. Genes Chromosomes Cancer. 2007 Sep;46(9):805-12. doi: 10.1002/gcc.20466. Genes Chromosomes Cancer. 2007. PMID: 17539022

5

Volatile fingerprints of cancer specific genetic mutations.

Peled N, Barash O, Tisch U, Ionescu R, Broza YY, Ilouze M, Mattei J, Bunn PA Jr, Hirsch FR, Haick H. Peled N, et al. Nanomedicine. 2013 Aug;9(6):758-66. doi: 10.1016/j.nano.2013.01.008. Epub 2013 Feb 18. Nanomedicine. 2013. PMID: 23428987 Free PMC article.

6

Is there clinical value to prognostic signatures in early-stage NSCLC?

Bunn PA Jr, Hirsch FR, Aisner DL. Bunn PA Jr, et al. Clin Cancer Res. 2014 Apr 1;20(7):1727-9. doi: 10.1158/1078-0432.CCR-13-3387. Epub 2014 Feb 28. Clin Cancer Res. 2014. PMID: 24583801 Free PMC article.

7

A randomized phase II chemoprevention trial of 13-CIS retinoic acid with or without alpha tocopherol or observation in subjects at high risk for lung cancer.

Kelly K, Kittelson J, Franklin WA, Kennedy TC, Klein CE, Keith RL, Dempsey EC, Lewis M, Jackson MK, Hirsch FR, Bunn PA, Miller YE. Kelly K, et al. Cancer Prev Res (Phila). 2009 May;2(5):440-9. doi: 10.1158/1940-6207.CAPR-08-0136. Epub 2009 Apr 28. Cancer Prev Res (Phila). 2009. PMID: 19401528 Free PMC article. Clinical Trial.

8

Increased EGFR gene copy number detected by fluorescent in situ hybridization predicts outcome in non-small-cell lung cancer patients treated with cetuximab and chemotherapy.

Hirsch FR, Herbst RS, Olsen C, Chansky K, Crowley J, Kelly K, Franklin WA, Bunn PA Jr, Varella-Garcia M, Gandara DR. Hirsch FR, et al. J Clin Oncol. 2008 Jul 10;26(20):3351-7. doi: 10.1200/JCO.2007.14.0111. J Clin Oncol. 2008. PMID: 18612151 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8 results

Results by year